CCC
BHC icon

Chelsea Counsel Company’s Bausch Health BHC Stock Holding History

Chelsea Counsel Company’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,200
Closed -$458K – 140
2014
Q4 		$458K Buy
+3,200
New +$430K 0.09% 87

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Chelsea Counsel Company's BHC Position: Q1 2015 in Review

Chelsea Counsel Company sold out of Bausch Health (BHC) in Q1 2015, closing a stake of 3,200 shares — an estimated $458K sold.

Chelsea Counsel Company first reported a position in BHC in Q4 2014 and held it in 1 quarter. The position peaked at $458K in Q4 2014. 556 funds tracked by Wall St. Rank hold BHC as of Q1 2015.

  • Chelsea Counsel Company reported no remaining Bausch Health position as of Q1 2015 after selling out during the quarter.
  • Chelsea Counsel Company sold 3,200 Bausch Health shares in Q1 2015, an estimated $458K.
  • Chelsea Counsel Company first reported a position in Bausch Health in Q4 2014 and held it in 1 quarter.
  • Chelsea Counsel Company's Bausch Health position peaked at $458K in Q4 2014.
  • 556 funds tracked by Wall St. Rank held Bausch Health as of Q1 2015.

Based on Chelsea Counsel Company's 13F filing for Q1 2015, filed 29 May 2015.